A comprehensive industry examination reveals what manufacturer disclosures, clinical study documentation, and delivery system ...

Immunotherapy has emerged in recent years as a new cancer treatment that is gentler than traditional chemotherapy and causes ...

Sankara Nethralaya, based in Chennai, is one of India’s most established tertiary eye care institutions. Known for its ...

Generative AI adoption, regulatory scrutiny, DEI policy shifts, real-world evidence, and rare disease economics emerged as key themes across these most-read Applied Clinical Trials articles shaping ...

The 2025 Community Oncology Conference, hosted by COA, reflected a commitment to patient-centered care, access, and ...

China National Nuclear Corporation (CNNC) held the Conference on Medical Transformation and Clinical Application of Nuclear ...

Intestinal Stem Cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for treating intractable intestinal diseases due to their low risk of rejection ...

Cancer has long remained a leading cause of death worldwide and in Hong Kong, accounting for 30% of all disease-related deaths in the city in 2025. While chemotherapy remains a major treatment ...

China, by contrast, is pursuing a state-led coordinated approach that integrates policy planning, clinical validation, and ...

The latest announcement is out from BullFrog AI Holdings, Inc. ( ($BFRG) ). In a December 30, 2025 letter to shareholders, BullFrog AI detailed a ...

OneOncology supports 33 practices, providing infrastructure and expertise for advanced therapies and value-based care, while ...

Health IT’s Legacy and the Road to Responsible AI by Dr. S. Yin Ho is an indispensable book about the current state of health information technology and how responsible AI could reshape our U.S.